Patent details

Basic Information

Publication number:

EP3062790

PCT Application Number:

AU2014001017

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP148592207

PCT Publication Number:

WO2015061832

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF CANCER

French Title of Invention:

COMBINAISONS PHARMACEUTIQUES POUR LE TRAITEMENT DU CANCER

German Title of Invention:

PHARMAZEUTISCHE KOMBINATIONEN ZUR BEHANDLUNG VON KREBS

SPC Number:

Dates

Filing date:

31/10/2014

Grant date:

08/03/2023

EP Publication Date:

07/09/2016

PCT Publication Date:

07/05/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/03/2023

EP B1 Publication Date:

08/03/2023

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

31/10/2023

Expiration date:

31/10/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

01/03/2023

 

 

Name:

Pitney Pharmaceuticals Pty Limited

Address:

Suite 39 1 Freshwater Parade, Claremont, WA 6010, Australia (AU)

Inventor

1

Name:

MORRIS, David Lawson

Address:

Australia (AU)

2

Name:

POURGHOLAMI, Mohammad Hossein

Address:

Australia (AU)

3

Name:

ASTON, Roger

Address:

Australia (AU)

Priority

Priority Number:

2013904239

Priority Date:

01/11/2013

Priority Country:

Australia (AU)

Classification

IPC classification:

A61K 31/277; A61K 31/65; A61K 31/704; A61K 31/513; A61K 31/337; A61K 31/7068; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202310

Publication date:

08/03/2023

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages